Crossmark

Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy

Crossref DOI link: https://doi.org/10.1007/s00401-026-03009-2

Published Online: 2026-04-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hill, Elizabeth

Linehan, Jacqueline

Farmer, Michael

Jakubcova, Tatiana

Hamdan, Shyma

Tomlinson, Andrew

Purro, Silvia

Argentina, Fabio

Jones, Emma

Kaye, Nicholas

Fitzhugh, Craig

de Silva, Rohan

Brandner, Sebastian

Collinge, John

Cunningham, Thomas J.

Mead, Simon
Funding

Funding for this research was provided by:

Medical Research Council

National Institute for Health Research
License Information

Text and Data Mining valid from 2026-04-22

Version of Record valid from 2026-04-22
More Information

Article History

Received: 22 January 2026

Revised: 24 March 2026

Accepted: 31 March 2026

First Online: 22 April 2026

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below